Hallucinogen Persisting Perception Disorder (HPPD) is a relatively rare but often debilitating condition in which individuals experience persistent or recurrent perceptual disturbances – especially visual distortions – long after the use of a hallucinogenic substance. Unlike acute intoxication or typical “flashbacks,” the symptoms in HPPD can persist for months or even years, significantly interfering with daily functioning (Halpern et al., 2016).

Psychologically, HPPD represents a chronic alteration in perceptual processing: the person is often aware that what they are seeing is not “real,” yet the experiences can provoke anxiety, depersonalization, or distress. As such, HPPD is more than just a transient memory of a drug trip; it is a disorder rooted in perceptual and attentional changes.

Symptoms of HPPD

The symptomatology of HPPD is heterogeneous, but several characteristic visual and non-visual symptoms have been documented in research and clinical reports:

Visual disturbances

• Palinopsia/afterimages: Seeing lingering or repeating images of objects, even after they have moved or disappeared.
• Trails/tracers: Objects seem to leave a trail behind as they move.
• Halos: Bright rings or glows around lights or objects.
• Visual snow: A grainy “static” overlay across the visual field, sometimes compared to television static.
• Color intensification or distortions: Colors may seem more vivid, or shapes may appear distorted (macropsia, micropsia).
• Flashes of light: Bright, brief flashes may appear without an external stimulus.

Psychological and emotional symptoms

• Anxiety and panic: The persistence of hallucinations can provoke ongoing anxiety or panic attacks.
• Depersonalization and derealization: Individuals may feel detached from themselves or perceive the external world as unreal.
• Cognitive difficulties: Concentration and memory may be affected due to the distressing visual experiences.

Symptoms can vary in intensity and may worsen in situations of fatigue, stress, or substance abuse. HPPD is often described in two subtypes: Type 1, which is transient and episodic, and Type 2, which is chronic and persistent (Halpern et al., 2016).

Causes of HPPD

HPPD is primarily associated with the use of hallucinogenic substances, including LSD, psilocybin mushrooms, MDMA, and other serotonergic psychedelics. However, the exact neurobiological mechanisms remain incompletely understood. The leading hypotheses include:

• Serotonergic system dysregulation

• Cortical disinhibition

• Neuroplastic changes

• Individual vulnerability

Diagnosis of HPPD

HPPD is diagnosed primarily through clinical evaluation. Key diagnostic criteria include:

• Presence of visual disturbances after cessation of hallucinogen use.
• Distress or functional impairment caused by these disturbances.
• Symptoms are not better explained by another mental health disorder or medical condition (American Psychiatric Association, 2013).
• Neuroimaging and other laboratory tests are generally used to rule out alternative causes, such as neurological disorders or vision problems.

Treatment Approaches

Treatment for HPPD is challenging due to the variable presentation and limited research. Therapeutic strategies often involve a combination of pharmacological and psychological interventions:

Pharmacological treatments

• Benzodiazepines may help reduce anxiety and perceptual hyperarousal.
• Anticonvulsants such as lamotrigine have shown some efficacy in reducing visual disturbances.
• Selective serotonin reuptake inhibitors (SSRIs) are sometimes used cautiously, although results are mixed, and they may exacerbate symptoms in some cases.

Psychological interventions

• Cognitive-behavioral therapy (CBT) helps patients manage anxiety and maladaptive responses to perceptual distortions.
• Mindfulness-based strategies can support grounding and acceptance, reducing distress associated with visual anomalies.
• Psychoeducation is crucial for understanding that the disorder is neurobiologically rooted can alleviate fear and catastrophizing.

Lifestyle modifications

• Reducing exposure to stress, sleep deprivation, and further hallucinogen use is essential.
• Supportive routines, proper sleep, and stress management strategies can improve symptom tolerance.

Support networks

• Peer or group support for individuals with HPPD can provide validation and coping strategies.
• Family education helps reduce stigma and ensures a supportive environment.

Conclusion

HPPD is a complex and often misunderstood disorder that blends neurological, psychological, and perceptual dimensions. Early recognition and a comprehensive approach combining therapy, pharmacology, and lifestyle adjustments are key to improving quality of life. While research is ongoing, increased awareness among mental health professionals and patients can facilitate timely intervention, reduce distress, and promote functional recovery.

Contribution: Dr (Prof.) R K Suri, Clinical Psychologist, life coach & mentor, TalktoAngel & Ms. Sakshi Dhankhar, Counselling Psychologist.

References

• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
• Halpern, J. H., Lerner, A., & Passie, T. (2016). A review of hallucinogen persisting perception disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD. Journal of Psychoactive Drugs, 48(4), 289–302. https://doi.org/10.1080/02791072.2016.1219795
• WebMD. (2024). Hallucinogen persisting perception disorder (HPPD). WebMD.
• https://www.talktoangel.com/blog/treatment-for-hallucinogen-induced-psychotic-disorder
• https://www.talktoangel.com/blog/causes-and-treatment-for-hallucination-and-delusion
• https://www.talktoangel.com/blog/understanding-the-causes-of-psychosis